These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37915358)

  • 1. A historical look using virtual microscopy: the first case report of adrenomyeloneuropathy (AMN).
    Budka H
    Free Neuropathol; 2023 Jan; 4():. PubMed ID: 37915358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
    Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.
    Shah N; Singh I
    Mol Neurobiol; 2017 Mar; 54(2):1392-1403. PubMed ID: 26843114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
    Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
    Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Single Nucleotide Deletions in the
    Dohr KA; Tokic S; Gastager-Ehgartner M; Stojakovic T; Dumic M; Plecko B; Dumic KK
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy.
    Li J; Wang H; He Z; Wang X; Tang J; Huang D
    BMC Neurol; 2019 Sep; 19(1):227. PubMed ID: 31526374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating ABCD1 mutations in a Taiwanese cohort with hereditary spastic paraplegia phenotype.
    Hsu SL; Chen YH; Chou CT; Chou YT; Tsai YS; Hsiao CT; Liao YC; Lee YC
    Parkinsonism Relat Disord; 2021 Nov; 92():7-12. PubMed ID: 34649108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges.
    Baker CV; Cady Keller A; Lutz R; Eveans K; Baumert K; DiPerna JC; Rizzo WB
    Int J Neonatal Screen; 2022 Apr; 8(2):. PubMed ID: 35645283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy.
    Stradomska TJ; Kubalska J; Janas R; Tylki-Szymanska A
    Eur J Endocrinol; 2012 Feb; 166(2):291-4. PubMed ID: 22048970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCD1 translation-initiator mutation demonstrates genotype-phenotype correlation for AMN.
    O'Neill GN; Aoki M; Brown RH
    Neurology; 2001 Dec; 57(11):1956-62. PubMed ID: 11739809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in the ABCD1 gene caused adrenomyeloneuropathy in the Chinese population.
    He R; Zhang J; Huang T; Cai G; Zou Z; Ye Q
    Front Neurol; 2023; 14():1126729. PubMed ID: 36925939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenoleukodystrophy and adrenomyeloneuropathy--clinical spectrum, pathobiochemical aspects, diagnosis and therapy].
    Zierz S; Tackmann W
    Fortschr Neurol Psychiatr; 1989 Dec; 57(12):527-34. PubMed ID: 2559009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Two Novel Mutations of
    Dong B; Lv W; Xu L; Zhao Y; Sun X; Wang Z; Cheng B; Fu Z; Wang Y
    Int J Endocrinol; 2022; 2022():5479781. PubMed ID: 35479665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy.
    Volmrich AM; Cuénant LM; Forghani I; Hsieh SL; Shapiro LT
    Appl Clin Genet; 2022; 15():111-123. PubMed ID: 35983253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy.
    Palakuzhiyil SV; Christopher R; Chandra SR
    World J Biol Chem; 2020 Nov; 11(3):99-111. PubMed ID: 33274015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.
    van Geel BM; Assies J; Weverling GJ; Barth PG
    Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: A case series.
    Matos T; Costa C; Araújo AN; do Vale S
    Endocrinol Diabetes Nutr (Engl Ed); 2023; 70(6):421-428. PubMed ID: 37356877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.